Abstract
Background
Venous thromboembolism (VTE) occurs in 3–11% of esophagectomy patients and is associated with increased mortality and morbidity. The use of validated VTE risk assessment tools and compliance with recommended practice guidelines remains unclear. In this study, we seek to determine the use of Caprini guideline indicated VTE prophylaxis and its effect on VTE and bleeding complications following esophagectomy.
Methods
Esophagectomy cases were identified from the Mayo Clinic electronic health records. Caprini score and VTE prophylaxis regimen received were determined retrospectively. VTE prophylaxis was identified as appropriate or inappropriate based on the Caprini score and prophylaxis received preoperative, during hospitalization, and after hospital discharge. Study cohorts were compared by Pearson Chi-square test, Fisher’s Exact test, Kruskal–Wallis test, and logistic regression models. Stata/MP 16.1 was used for analysis. Odds ratios and 95% confidence intervals were reported for logistic regression models. A p-value < 0.05 was considered significant.
Results
Four hundred and fifty-six esophagectomy cases were analyzed. The median Caprini score was thirteen. Appropriate prophylaxis resulted in a 6.9-fold reduction in inpatient VTE. All 30- and 90-day post-discharge VTEs occurred in those not receiving Caprini guideline-indicated VTE prophylaxis. Inpatient, 30- and 90-day post-discharge bleeding rates were 7.68%, 0.91%, and 2.11%, respectively; however, bleeding was not increased with receipt of appropriate prophylaxis.
Conclusion
In this esophagectomy cohort, Caprini guideline indicated VTE prophylaxis resulted in reduced inpatient VTE events without increasing bleeding complications. Risk-based VTE prevention measures should be considered in this patient cohort known to be at heightened risk for postoperative VTE.
Similar content being viewed by others
Data Availability
The data utilized for this study is not publicly available due as the data contains protected health information.
References
Henke, P.K., et al., Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association. Circulation, 2020. 141(24): p. e914-e931.
Mukherjee, D., et al., Postoperative Venous Thromboembolism Rates Vary Significantly After Different Types of Major Abdominal Operations. Journal of Gastrointestinal Surgery, 2008. 12(11): p. 2015.
Martin, J.T., et al., Identifying Esophagectomy Patients at Risk for Predischarge Versus Post-discharge Venous Thromboembolism. The Annals of Thoracic Surgery, 2015. 100(3): p. 932-938.
De Martino, R.R., et al., Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. Journal of Vascular Surgery, 2012. 55(4): p. 1035-1040.e4.
Mantziari, S., et al., Incidence and Risk Factors Related to Symptomatic Venous Thromboembolic Events After Esophagectomy for Cancer. The Annals of Thoracic Surgery, 2016. 102(3): p. 979-984.
Byrne, M., et al., Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery. British Journal of Cancer, 2010. 102(1): p. 73-79.
Tsutsumi, K., et al., Pulmonary thromboembolism after surgery for esophageal cancer: Its features and prophylaxis. Surgery Today, 2000. 30(5): p. 416-420.
Chen, S.Y., et al., Post-discharge complications after esophagectomy account for high readmission rates. World J Gastroenterol, 2016. 22(22): p. 5246-53.
Rogers, S.O., Jr., et al., Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg, 2007. 204(6): p. 1211-21.
Pannucci, C.J., et al., A validated risk model to predict 90-day VTE events in postsurgical patients. Chest, 2014. 145(3): p. 567-573.
Pannucci, C.J., et al., Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery. Ann Surg, 2012. 255(6): p. 1093-9.
Bahl, V., et al., A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Method. Annals of Surgery, 2010. 251(2): p. 344-350.
Shuman, A.G., et al., Stratifying the risk of venous thromboembolism in otolaryngology. Otolaryngol Head Neck Surg, 2012. 146(5): p. 719-24.
Zhou, H.X., et al., Validation of the Caprini risk assessment model in Chinese hospitalized patients with venous thromboembolism. Thromb Res, 2012. 130(5): p. 735–40.
Obi, A.T., et al., Validation of the Caprini Venous Thromboembolism Risk Assessment Model in Critically Ill Surgical Patients. JAMA Surg, 2015. 150(10): p. 941–8.
Hewes, P.D., et al., Evaluation of the Caprini Model for Venothromboembolism in Esophagectomy Patients. Ann Thorac Surg, 2015. 100(6): p. 2072–8.
Sterbling, H.M., et al., Caprini Risk Model Decreases Venous Thromboembolism Rates in Thoracic Surgery Cancer Patients. Ann Thorac Surg, 2018. 105(3): p. 879–885.
Sterbling, H.M., et al., Caprini Risk Model Decreases Venous Thromboembolism Rates in Thoracic Surgery Cancer Patients. The Annals of Thoracic Surgery, 2018. 105(3): p. 879–885.
Zwischenberger, B.A., et al., Venous Thromboembolism Prophylaxis For Esophagectomy: A Survey of Practice Patterns Among Thoracic Surgeons. The Annals of Thoracic Surgery, 2016. 101(2): p. 489-494.
Findlay, J.M., et al., Enhanced Recovery for Esophagectomy: A Systematic Review and Evidence-Based Guidelines. Annals of Surgery, 2014. 259(3): p. 413–431.
Gould, M.K., et al., Prevention of VTE in Nonorthopedic Surgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012. 141(2, Supplement): p. e227S–e277S.
Agzarian, J., et al., Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi survey. J Thorac Dis, 2017. 9(1): p. 80–87.
Moriarty, J.P., et al., Going Beyond Administrative Data: Retrospective Evaluation of an Algorithm Using the Electronic Health Record to Help Identify Bleeding Events Among Hospitalized Medical Patients on Warfarin. Am J Med Qual, 2017. 32(4): p. 391–396.
Yoshida, N., et al., Prophylaxis of Postoperative Venous Thromboembolism Using Enoxaparin After Esophagectomy: A Prospective Observational Study of Effectiveness and Safety. Ann Surg Oncol, 2018. 25(8): p. 2434–2440.
Akhtar-Danesh, G.-G., N. Akhtar-Danesh, and Y. Shargall, Venous Thromboembolism in Surgically Treated Esophageal Cancer Patients: A Provincial Population-Based Study. TH Open, 2022. 06(03): p. e168–e176.
Bergqvist, D., et al., Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer. New England Journal of Medicine, 2002. 346(13): p. 975–980.
Kakkar, V.V., et al., Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. Journal of Thrombosis and Haemostasis, 2010. 8(6): p. 1223–1229.
Rasmussen, M.S., et al., Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open‐label study. Journal of Thrombosis and Haemostasis, 2006. 4(11): p. 2384–2390.
Hanna, N.M., et al., Incidence, Timing, and Outcomes of Venous Thromboembolism in Patients Undergoing Surgery for Esophagogastric Cancer: A Population-Based Cohort Study. Annals of Surgical Oncology, 2022. 29(7): p. 4393–4404.
Trinh, V.Q., et al., Venous Thromboembolism After Major Cancer Surgery: Temporal Trends and Patterns of Care. JAMA Surgery, 2014. 149(1): p. 43–49.
Merkow et al. Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg, 2011. 254(1): p. 131–7.
Shah, S.P., et al., Why are patients being readmitted after surgery for esophageal cancer? The Journal of Thoracic and Cardiovascular Surgery, 2015. 149(5): p. 1384–1391.
Goel, N.J., et al., Nationwide Analysis of 30-Day Readmissions After Esophagectomy: Causes, Costs, and Risk Factors. The Annals of Thoracic Surgery, 2020. 109(1): p. 185–193.
Tanaka, Y., et al., Efficacy and Safety of Enoxaparin for Prophylaxis of Postoperative Venous Thromboembolism After Esophagectomy: A Single-center Prospective Randomized Controlled Phase II Study. Anticancer Research, 2019. 39(5): p. 2615.
Krell, R.W., et al., Variation in Hospital Thromboprophylaxis Practices for Abdominal Cancer Surgery. Annals of Surgical Oncology, 2016. 23(5): p. 1431–1439.
Streiff, M.B., et al., Venous thromboembolic disease. Journal of the National Comprehensive Cancer Network, 2013. 11(11): p. 1402–1429.
Farge, D., et al., International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Journal of Thrombosis and Haemostasis, 2013. 11(1): p. 56–70.
Ruff, S.M., et al., Practice patterns of VTE chemoprophylaxis after discharge following hepatic and pancreatic resections for cancer: a survey of hepatopancreatobiliary surgeons. Journal of thrombosis and thrombolysis, 2019. 48: p. 119–124.
Merkow, R.P., et al., Adherence with post-discharge venous thromboembolism chemoprophylaxis recommendations after colorectal cancer surgery among elderly Medicare beneficiaries. Ann Surg, 2014. 260(1): p. 103–8.
40 Lui D.S., Newbold R, Stevens S. et al. Early Versus Postoperative Chemical Thromboprophylaxis Is Associated with Increased Bleeding Risk Following Abdominal Visceral Resections: a Multicenter Cohort Study. Journal of Gastrointestinal Surgery (2022) 26:1495–1502.
Hachey, K.J., et al., Caprini venous thromboembolism risk assessment permits selection for post-discharge prophylactic anticoagulation in patients with resectable lung cancer. J Thorac Cardiovasc Surg, 2016. 151(1): p. 37-44.e1.
Kakkar, A.K., Prevention of venous thromboembolism in the cancer surgical patient. Journal of clinical oncology, 2009. 27(29): p. 4881–4884.
Song, J.-Q., et al., Low molecular weight heparin once versus twice for thromboprophylaxis following esophagectomy: a randomised, double-blind and placebo-controlled trial. Journal of Thoracic Disease, 2015. 7(7): p. 1158.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing Interests
The authors have no conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Appendix
Caprini guided VTE prophylaxis
Caprini Score | Recommended VTE Prophylaxis |
---|---|
1-2 | Either compression device or anticoagulant prophylaxis preoperatively and postoperatively. |
3-4 | Compression device and anticoagulant prophylaxis, preoperatively and postoperatively. |
5-8 | Compression device and anticoagulant prophylaxis preoperatively and postoperatively, and discharge anticoagulant prophylaxis x 7-10 days |
>8 | Compression device and anticoagulant prophylaxis preoperatively and postoperatively, and discharge anticoagulant prophylaxis x 30 days |
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Edwards, M.A., Hussain, M.W.A., Spaulding, A.C. et al. Can Risk-Based Thromboprophylaxis Practice Guidelines be Safely Used in Esophagectomy Cases? Experience of an Academic Health System. J Gastrointest Surg 27, 2045–2056 (2023). https://doi.org/10.1007/s11605-023-05815-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-023-05815-5